TopCat is a forward looking company that wants to put the customer at the heart of all we do. TopCat aims to provide effective and cost conscious analytical products for the food, pharmaceutical and environmental markets. TopCat products will be based on immunoassay (ELISA) and Polymerase Chain Reaction (PCR) platforms. These platforms will be used to create products that our market research has shown are most appropriate for our target markets.
Our Consultancy Service is open to all Stakeholder Partners. We want to discuss ways in which TopCat can help your business. This can be through discussion of our research, products, or future developments. We also want to support Stakeholders that have existing technology platforms that may require troubleshooting or more effective deployment.
The TopCat approach is to be open to ideas but mindful of the needs of our Stakeholder Partners. From our in-house knowledge and expertise, we have decided to take a pragmatic approach to technology platforms and use well established methods to drive our Stakeholders’ and TopCat’s success. Thus, TopCat will primarily develop products based round ELISA and PCR platforms. The initial focus will be on the ELISA products as these are, in TopCat’s opinion, quicker to develop.
The overall vision is to create screening assays on the ELISA platform and then use PCR or IMMUNO-PCR to develop confirmatory tests, in the relevant market sectors. However, our research, as with all our efforts, is driven by our Stakeholders and Stakeholder Partners. Preferential consultancy rates are offered to BioNow members.
TopCat Research Limited
Contact details: Contact: Anthony Cope (Research Director)
Tel: 01248 354326
Mob: 07895296673
E-mail: anthony.cope@topcat-research.com
Web: www.topcat-research.com
